SURVEY: Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma

Help Improve Bispecific Antibody Delivery for Multiple Myeloma Patients!

The Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma was published November 2024. Created by the Equity in Multiple Myeloma Bispecific Research and Access (EMMBRAce) Bispecific Antibody Implementation Group, aims to enhance the delivery and accessibility of bispecific antibodies for patients with multiple myeloma.

 

📄 Read the Consensus Framework here: Consensus Framework Document 

 

The EMMBRAce group would like your feedback to refine this framework and project, ultimately improving treatment options for patients. Please take a moment to complete the survey and share it with your network.

 

🗓️ Survey Closes: February 27th

 

🔗 Take the Survey: https://qualtrics.ucl.ac.uk/jfe/form/SV_0Ilnj2WKuNB9lEa

 

Thank you for your valuable input and support!

Latest News

By Suriya Marshall on 27th September 2026

Cancer Vaccines: “Transforming Vaccine Delivery Through Innovation”

Session Title: Cancer Vaccines: “Transforming Vaccine Delivery Through Innovation” When: 12th October 2026. From 1-2pm Online event  Session Outline: This presentation explores the role of cancer vaccines in transforming cancer…

Read article
By BOPA on 8th September 2026

Register now: Immunotherapy: Beyond Checkpoint Inhibitors

Immunotherapy: Beyond Checkpoint Inhibitors WHEN: Tuesday 17th November 2026 WHERE:  Wellcome Collection, 183 Euston Road, London, NW1 BE COST: A non-refundable payment of £25.00. We are pleased to announce registration is now available for…

Read article
By BOPA Executive Committee on 7th September 2026

Royal College of Pharmacy launch its new Enhanced Curriculum and Credentialing Pathway

We are delighted to see the Royal College of Pharmacy launch its new Enhanced Curriculum and Credentialing Pathway today. This curriculum is the product of a truly collaborative effort across…

Read article
By NHS Infusions and Special Medicines Programme on 4th September 2026

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications The Infusions and Special Medicines Programme is inviting expressions of interest for…

Read article